Kilitch Drugs (India) Ltd
KILITCHKilitch Drugs (India) Ltd
KILITCH
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.17 | 2.66 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.65 | 4.77 | 0.76% |
Forecast & Ratings
Detailed Forecastfrom 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 21.75 | 23.77 | 29.79 | 53.89 | 86.49 | 57.45 | 71.19 | 117.14 | 142.52 | 145.22 | ||||||||||
Raw Materials | 6.49 | 8.92 | 10.50 | 26.44 | 48.35 | 29.82 | 36.22 | 65.48 | 74.53 | 122.37 | ||||||||||
| Power & Fuel Cost | 0.82 | 0.97 | 1.06 | 1.11 | 1.42 | 1.62 | 1.57 | 2.25 | 2.15 | |||||||||||
| Employee Cost | 3.13 | 3.47 | 3.38 | 4.30 | 5.28 | 5.69 | 5.24 | 6.18 | 11.73 | |||||||||||
| Selling & Administrative Expenses | 4.42 | 5.17 | 6.98 | 8.19 | 12.56 | 11.50 | 11.17 | 17.88 | 23.53 | |||||||||||
| Operating & Other expenses | 5.94 | 6.76 | 7.27 | 5.28 | 7.60 | 4.28 | 9.01 | 11.94 | 9.93 | |||||||||||
EBITDA | 0.95 | -1.52 | 0.60 | 8.57 | 11.28 | 4.54 | 7.98 | 13.41 | 20.65 | 22.85 | ||||||||||
| Depreciation/Amortization | 1.85 | 10.05 | 9.76 | 2.04 | 2.05 | 2.00 | 1.99 | 2.47 | 3.55 | 3.44 | ||||||||||
| PBIT | -0.90 | -11.57 | -9.16 | 6.53 | 9.23 | 2.54 | 5.99 | 10.94 | 17.10 | 19.41 | ||||||||||
| Interest & Other Items | 0.05 | 0.06 | 0.16 | 0.42 | 0.65 | 0.94 | 0.88 | 1.33 | 5.08 | 5.75 | ||||||||||
| PBT | -0.95 | -11.63 | -9.32 | 6.11 | 8.58 | 1.60 | 5.11 | 9.61 | 12.02 | 13.66 | ||||||||||
| Taxes & Other Items | -0.66 | -0.44 | -0.43 | 0.96 | 4.76 | 0.77 | 1.36 | 2.25 | 1.56 | 1.94 | ||||||||||
| Net Income | -0.29 | -11.19 | -8.89 | 5.15 | 3.82 | 0.83 | 3.75 | 7.36 | 10.46 | 11.72 | ||||||||||
| EPS | -0.22 | -8.46 | -6.72 | 3.82 | 2.63 | 0.54 | 2.42 | 4.74 | 6.71 | 7.52 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.50 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.13 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Kilitch Drugs (India) Ltd | 38.28 | 2.66 | — |
| Sun Pharmaceutical Industries Ltd | 32.81 | 4.69 | 0.99% |
| Cipla Ltd | 34.18 | 4.04 | 0.72% |
| Dr Reddy's Laboratories Ltd | 20.63 | 3.99 | 0.72% |
Price Comparison
Compare KILITCH with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2019
Dividend/Share
₹0.50
Ex DateEx Date
Sep 20, 2019
Cash Dividend
Ex DateEx DateSep 18, 2018
Dividend/Share
₹0.50
Ex DateEx Date
Sep 18, 2018
Cash Dividend
Ex DateEx DateSep 24, 2012
Dividend/Share
₹30.00
Ex DateEx Date
Sep 24, 2012
Cash Dividend
Ex DateEx DateAug 18, 2011
Dividend/Share
₹1.00
Ex DateEx Date
Aug 18, 2011
Cash Dividend
Ex DateEx DateOct 14, 2010
Dividend/Share
₹1.00
Ex DateEx Date
Oct 14, 2010
News & Opinions
Kilitch Drugs Standalone March 2022 Net Sales at Rs 32.03 crore, up 51.49% Y-o-Y
1 year ago•Moneycontrol
Kilitch Drugs commences Rs100 crore new facility expansion plan
1 year ago•India Infoline
Kilitch Drugs (India) reports standalone net profit of Rs 2.89 crore in the June 2021 quarter
2 years ago•Business Standard
Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant; Stock surges 5%
2 years ago•India Infoline
Kilitch Drugs (India) reports consolidated net profit of Rs 0.71 crore in the March 2021 quarter
2 years ago•Business Standard
Buzzing Stocks | Bharti Airtel, RIL, Railtel, Bank Of Maharashtra, Equitas Holdings, Tata Chemicals, Hindustan Aeronautics
2 years ago•Moneycontrol
Board of Kilitch Drugs (India) approves change in CFO and company secretary
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 21.47%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.03% to 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 15.22%, vs industry avg of 9.81%